Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-05-06

Clinical Trial Update: Barberry and Cardiometabolic Risk Factors in Individuals With Hypertriglyceridemia [NA]

View source ↗

Summary

A completed clinical trial evaluating the effects of Barberry on cardiometabolic risk factors in individuals with hypertriglyceridemia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Barberry (Barberry extract (Berberis vulgaris))

Snippet

Sponsor: Shahid Beheshti University | Conditions: Hyperlipidemias, Hypertriglyceridemia | NA | Status: COMPLETED